The five key areas to drive growth of UK’s pharmaceutical sector

These 5 things are what pharmaceutical companies should be focusing on to maximise their growth in the UK.

The NHS is 70 – Claudia Rubin asks: what’s next?

From birthday teas to big policy, blood donor drives to special 10p coins, the 70th anniversary of the creation of the NHS is getting...

It’s time for a greater role for pharmacists in asthma management

I’ve returned from a Saturday morning in community pharmacy practice and am reflecting on the number of patients I saw with asthma. I checked...

Beyond politics; patient groups and the art of influence

“What is a patient group?”, a friend of mine enquired during one of our recent regular political discussions. It struck me afterwards that given...

The real cost of over the counter prescriptions

  NHS England recently published its guidance for CCGs on the over the counter (OTC) items which should not be routinely prescribed in primary care...

David wants understanding between NHS & industry

Not who you say I am: Pharma companies need to be clear who they’re talking to and why they’re talking to them. Last week a pharma...

Two takes: Bad habits – help or hindrance?

  In this month’s emotive opinion battle, we ask two healthcare professionals if we should be encouraging patients to evaluate their lifestyle choices, or are...

Pharmacists are the last step between HCPs and patients

Having the right medicine at the right time and administered in the right way can be the difference between that patient continuing their treatment...

AI is launching healthcare into the future

With tales of Victorian era conditions on hospital wards, chronic ambulance queues and surgery delays reminiscent of the NHS’s nadir in the early 1990s,...

Does a pharmacy career appeal to young people?

  For pharmacy graduates forcing doors open is essential. Over 30 years ago I made the decision to study pharmacy at Nottingham University, with little understanding...

Latest articles

doctors and patients to show Addressing the wellbeing of doctors - new report from GMC

Addressing the wellbeing of doctors – new report from GMC

A new report on the wellbeing of doctors commissioned by the General Medical Council (GMC) says that UK health services could be world leaders...
woman of colour on phone with app icons to show Industry figures recognised as Top 100 Most Influential BAME Leaders in Tech

Industry figures recognised as Top 100 Most Influential BAME Leaders in Tech

Industry figures have been announced as part of the #IB100 – a list of the top 100 most influential black, Asian and minority ethnic...
blood droplets containing type 1 and type 2 in lettering to show Lack of knowledge about type 2 diabetes risk factors

Lack of knowledge about type 2 diabetes risk factors – survey

An international survey published to mark World Diabetes Day shows a lack of knowledge about type 2 diabetes risk factors. The results of the...

Popular articles

woman of colour on phone with app icons to show Industry figures recognised as Top 100 Most Influential BAME Leaders in Tech

Industry figures recognised as Top 100 Most Influential BAME Leaders in Tech

Industry figures have been announced as part of the #IB100 – a list of the top 100 most influential black, Asian and minority ethnic...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...

Market Access in practice: do you have a strategy?

This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...
Woman interviewing man at a desk demonstrating a successful key account manager

How to be a successful key account manager

Pf asked two consultants from top pharma recruitment consultancies for their views on what it takes to be a successful key account manager.   Andy Boyd, Senior...
pharmafield logo - pharma news

The Twilight Zone

Classified drugs, which are potentially dangerous and liable to abuse, have legitimate uses but also turn up on the black market. What does this mean for industry – and how has the internet affected this problem?

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription